表紙
市場調査レポート

トキソプラズマ症:世界の治験レビュー

Toxoplasmosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322175
出版日 ページ情報 英文 60 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
トキソプラズマ症:世界の治験レビュー Toxoplasmosis Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 60 Pages
概要

当レポートでは、トキソプラズマ症の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • トキソプラズマ症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:感染症の治験におけるトキソプラズマ症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:感染症の治験におけるトキソプラズマ症の割合

E7諸国における段階別の治験件数

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Glaxo Wellcome GmbH & Co. KG
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • Renmin Hospital of Wuhan University
    • Zentrum fur Integrative Psychiatrie
    • Rafik Hariri University Hospital
    • Palo Alto Medical Foundation for Health Care, Research & Education
    • Arak University of Medical Sciences
    • University of Campinas, Brazil
    • University Hospital, Limoges
    • National Institutes of Health Clinical Center
    • Assistance Publique - Hopitaux de Paris

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2524CTIDB

GlobalData's clinical trial report, "Toxoplasmosis Global Clinical Trials Review, H2, 2014" provides data on the Toxoplasmosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Toxoplasmosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Toxoplasmosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Toxoplasmosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Toxoplasmosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Toxoplasmosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Glaxo Wellcome GmbH & Co. KG
      • Clinical Trial Overview of Glaxo Wellcome GmbH & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Renmin Hospital of Wuhan University
      • Clinical Trial Overview of Renmin Hospital of Wuhan University
      • Zentrum fur Integrative Psychiatrie
      • Clinical Trial Overview of Zentrum fur Integrative Psychiatrie
      • Rafik Hariri University Hospital
      • Clinical Trial Overview of Rafik Hariri University Hospital
      • Palo Alto Medical Foundation for Health Care, Research & Education
      • Clinical Trial Overview of Palo Alto Medical Foundation for Health Care, Research & Education
      • Arak University of Medical Sciences
      • Clinical Trial Overview of Arak University of Medical Sciences
      • University of Campinas, Brazil
      • Clinical Trial Overview of University of Campinas, Brazil
      • University Hospital, Limoges
      • Clinical Trial Overview of University Hospital, Limoges
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Toxoplasmosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Toxoplasmosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Toxoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Glaxo Wellcome GmbH & Co. KG, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Renmin Hospital of Wuhan University, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zentrum fur Integrative Psychiatrie, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rafik Hariri University Hospital, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Palo Alto Medical Foundation for Health Care, Research & Education, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Campinas, Brazil, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Limoges, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Toxoplasmosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Toxoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Toxoplasmosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Toxoplasmosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Toxoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Toxoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Toxoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top